Novartis Partnering

Reimagining Medicine through Partnerships

At Novartis, we believe that biomedical innovation will have an unparalleled impact on all humankind. We are excited at being leaders in this, and we are constantly looking for partners who want to share the journey with us.

Partnering Opportunities

We are looking for partners as excited to try to bend the curve of life as we are.

Please select your area of partnering interest from one of the sections below and we will connect you to the appropriate person.

  • Scientists mark up their work on whiteboard

    Innovative Medicines

    Made up of two business units – Novartis Pharmaceuticals and Novartis Oncology – our Innovative Medicines efforts, research, develop and commercialize innovative medicines to enhance health outcomes for patients and HCPs.

  • Generics & Biosimilars

    Our Sandoz Division is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

  • A motorised vehicle automated by blockchain

    Digital Solutions

    Building a leading digital and data science platform through bold partnerships with industry leaders, and continuous investment in people and data management.

Our Approach to Partnering

It is an energizing thing to work with Novartis, we want to create relationships, not just transactions – learn what you can expect if you collaborate with us and importantly, what makes Novartis different.

Learn More

NIBR Science of Therapeutics Symposium: Coronavirus Antivirals

Join us for a ‘hard core’ science event focused on finding therapeutic solutions to this ongoing health crisis.

Register Now

Podcast

Beyond the Deal - Making Sense of M&A, Alliances and Divestments

Join Novartis executives Christelle Sanglier-Bornstein, Global Head of Post-Merger Integration, and Knut Sturmhoefel, Global Head of Alliance Management, as they discuss establishing Novartis as a Partner of Choice across its portfolio of businesses with BTD Partner, Nick Palmer.

 

Read More

Novartis at JP Morgan 2021

CEO Vas Narasimhan reflections during JP Morgan Healthcare Conference

Discussing with CNBC Television about ESG and the impact of COVID-19 for the pharmaceutical industry.

Watch Video

Interview with Marie-France Tschudin, President of Novartis Pharmaceuticals

Novartis is making an effort to think differently about improving patient access to its existing medicines. 

Learn More

Featured partnerships
  • Molecular Partners

    Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19.

  • Portrait of Chinese woman smiling

    Tencent

    Co-developing AI Nurse, improving standards of care for heart failure patients in China.

  • Production associates view screen

    Amazon Web Services

    We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered.

  • Researcher looking at data on an iPad

    Microsoft

    Novartis and Microsoft announced a multiyear alliance which will leverage data & Artificial Intelligence (AI).

Learn more about us

Sourcing innovation, strategically

Phil Gotwals, the Head of BD&L at NIBR, talks about his vision for the future of business development for research.

Read the Story

The Novartis Biome

A catalyst for impactful digital collaboration to create better healthcare solutions and seamless experiences for patients and caregivers, at scale.

Learn More